A case study comparing a randomized withdrawal trial and a double‐blind long‐term trial for assessing the long‐term efficacy of an antidepressant
Craig Mallinckrodt(Biogen (United States)), Larry Alphs(Pfizer (United States)), David Pérahia(École Normale Supérieure Paris-Saclay), Christy Chuang‐Stein(Pfizer (United States)), Jeffrey H. Schwartz(Pfizer (United States)), Donald Archibald(Bristol-Myers Squibb (United States)), Michael J. Detke(Eli Lilly (United States)), P. McSorley(GlaxoSmithKline (United States))
Cited by 18
Related Papers
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
|Clinical Infectious Diseases|2015|340
Evaluation of the configurational entropy for proteins: application to molecular dynamics simulations of an α-helix
|Macromolecules|1984|248
Internal and interfacial dielectric properties of cytochrome c from molecular dynamics in aqueous solution.
|Proceedings of the National Academy of Sciences|1995|213